Paper - WANFANG MED ONLINE

You Position: Home > Paper

Microbiota-targeted therapeutics in gastrointestinal diseases

( views:40, downloads:0 )

Author:: No author available

Journal Title:: World Chinese Journal of Digestology

Issue:: 15

DOI:: 10.11569/wcjd.v29.i15.841

Key Word:: 肠道菌群;肠易激综合征;炎症性肠病;结直肠癌;靶向菌群疗法

Abstract：近年来,越来越多的疾病被发现与肠道菌群失调相关,特别是近5年来一些颠覆性的发现使得肠道菌群成为健康、疾病领域的热点问题.作为机体生物过程的重要协调者以及多种疾病发生发展过程中的共同参与者,加之其组成和功能的可塑性,肠道菌群逐渐成为一个极富吸引力的预防和治疗疾病的靶标而引起研究者的高度重视.本文就肠道菌群与肠易激综合征、IBD和结直肠癌的关系进行了整理,并介绍了在胃肠病中以肠道菌群为靶向的治疗策略的现状,以期为靶向肠道菌群治疗策略的应用提供借鉴.

Reference

[1]Gianluca Ianiro,Leonardo H. Eusebi,Christopher J. Black,etc.Systematic review with meta‐analysis: efficacy of faecal microbiota transplantation for the treatment of irritable bowel syndrome[J].2019,50(3).
[2]Hill Colin.Balancing the risks and rewards of live biotherapeutics[J].2019,17(3).
[3]Patrice D,Cani.Microbiota and metabolites in metabolic diseases.[J].2019.
[4]Paramsothy, Sudarshan,Paramsothy, Ramesh,Rubin, David T.,etc.Faecal Microbiota Transplantation for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis[J].2017,11(10).
[5]Selina R,Cox,James O,Lindsay,Sébastien,Fromentin,etc.Effects of Low FODMAP Diet on Symptoms, Fecal Microbiome, and Markers of Inflammation in Patients With Quiescent Inflammatory Bowel Disease in a Randomized Trial.[J].2020,158(1).
[6]Bradley C, Johnston,Joshua Z, Goldenberg,Patricia C, Parkin.Probiotics and the Prevention of Antibiotic-Associated Diarrhea in Infants and Children.[J].2016,(14).
[7]Long Xiaohang,Wong Chi Chun,Tong Li,etc.Peptostreptococcus anaerobius promotes colorectal carcinogenesis and modulates tumour immunity[J].2019,4(12).
[8]Goldenberg, Joshua Z.,Mertz, Dominik,Johnston, Bradley C..Probiotics to Prevent Clostridium difficile Infection in Patients Receiving Antibiotics[J].2018,320(5).
[9].Mitteilungen der DRL[J].2021,80(6).
[10]Yilmaz, Bahtiyar,Juillerat, Pascal,Oyas, Ove,etc.Microbial network disturbances in relapsing refractory Crohn's disease[J].2019,25(2).
[11]El-Salhy, Magdy,Hatlebakk, Jan Gunnar,Gilja, Odd Helge,etc.Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study[J].2020,69(5).
[12]Ofir, Gal,Sorek, Rotem.Contemporary Phage Biology: From Classic Models to New Insights[J].2018,172(6).
[13]McDonald, L Clifford,Gerding, Dale N,Johnson, Stuart,etc.Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)[J].2018,66(7).
[14]Paramsothy, Sudarshan,Kamm, Michael A.,Kaakoush, Nadeem O.,etc.Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial[J].2017,389(10075).
[15]Colombel, Jean-Frederic,Shin, Andrea,Gibson, Peter R..AGA Clinical Practice Update on Functional Gastrointestinal Symptoms in Patients With Inflammatory Bowel Disease: Expert Review[J].2019,17(3).
[16]Dore Maria Pina,Rocchi Chiara,Longo Nunzio Pio,etc.Effect of Probiotic Use on Adverse Events in Adult Patients with Inflammatory Bowel Disease: a Retrospective Cohort Study[J].2019,12(1).
[17]Zhenwei, Dai,Olabisi Oluwabukola, Coker,Geicho, Nakatsu,etc.Multi-cohort analysis of colorectal cancer metagenome identified altered bacteria across populations and universal bacterial markers.[J].2018,6(1).
[18]Hill Colin,Guarner Francisco,Reid Gregor,etc.The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic[J].2014,11(8).
[19].Guidelines for diagnosis, treatment, and prevention of clostridium difficile infections[J].2013,108(4).
[20]Yachida Shinichi,Mizutani Sayaka,Shiroma Hirotsugu,etc.Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer[J].2019,25(6).
[21]Matthew T,Henke,Douglas J,Kenny,Chelsi D,Cassilly,etc.Ruminococcus gnavus, a member of the human gut microbiome associated with Crohn's disease, produces an inflammatory polysaccharide.[J].2019,116(26).
[22]Shuai,Wang,Rene,Martins,Megan C,Sullivan,etc.Diet-induced remission in chronic enteropathy is associated with altered microbial community structure and synthesis of secondary bile acids.[J].2019,7(1).
[23]Pittayanon, Rapat,Lau, Jennifer T.,Yuan, Yuhong,etc.Gut Microbiota in Patients With Irritable Bowel Syndrome-A Systematic Review[J].2019,157(1).
[24]Bhandare, Sudhakar,Colom, Joan,Baig, Abiyad,etc.Reviving Phage Therapy for the Treatment of Cholera[J].2019,219(5).
[25]Moayyedi P,Garg AX,Collins SM,etc.Eight year prognosis of postinfectious irritable bowel syndrome following waterborne bacterial dysentery.[J].2010,59(5).
[26]Walter, Jens,Armet, Anissa M.,Finlay, B. Brett,etc.Establishing or Exaggerating Causality for the Gut Microbiome: Lessons from Human Microbiota-Associated Rodents[J].2020,180(2).
[27]Olesen, Scott W.,Leier, McKenzie M.,Alm, Eric J.,etc.Searching for superstool: maximizing the therapeutic potential of FMT[J].2018,15(7).
[28].The Human Gut Phage Community and Its Implications for Health and Disease[J].2017,9.
[29]Ling Jin,Xiaoming Shi,Jing Yang,etc.Gut microbes in cardiovascular diseases and their potential therapeutic applications[J].2021,(5).
[30]Chung, Liam,Orberg, Erik Thiele,Geis, Abby L.,etc.Bacteroides fragilis Toxin Coordinates a Pro-carcinogenic Inflammatory Cascade via Targeting of Colonic Epithelial Cells[J].2018,23(2).
[31]DeFilipp, Zachariah,Bloom, Patricia P.,Soto, Mariam Torres,etc.Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant[J].2019,381(21).
[32]Plaza-Diaz, Julio,Ruiz-Ojeda, Francisco Javier,Gil-Campos, Mercedes,etc.Mechanisms of Action of Probiotics[J].2019,10(suppl_1).
[33]Lebeer, Sarah,Bron, Peter A.,Marco, Maria L.,etc.Identification of probiotic effector molecules: present state and future perspectives[J].2018,49.
[34].Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease[J].2014,8(10).
[35]Monteagudo-Mera Andrea,Rastall Robert A.,Gibson Glenn R.,etc.Adhesion mechanisms mediated by probiotics and prebiotics and their potential impact on human health[J].2019,103(16).
[36].Irritable bowel syndrome: a gut microbiota-related disorder?[J].2017,312(1).
[37]Franzosa Eric A.,Sirota-Madi Alexandra,Avila-Pacheco Julian,etc.Gut microbiome structure and metabolic activity in inflammatory bowel disease[J].2018,4(2).
[38]Ji,G.,Luo,W.,Zhang,F.,etc.Should we standardize the 1,700-year-old fecal microbiota transplantation[J].2012,107(11).
[39]Ni Josephine,Wu Gary D.,Albenberg Lindsey,etc.Gut microbiota and IBD: causation or correlation?[J].2017,14(10).
[40]Arnau,Vich Vila,Floris,Imhann,Valerie,Collij,etc.Gut microbiota composition and functional changes in inflammatory bowel disease and irritable bowel syndrome.[J].2018,10(472).
[41]Neurath Markus F..Host–microbiota interactions in inflammatory bowel disease[J].2019,17(2).
[42]Costello, Samuel P.,Hughes, Patrick A.,Waters, Oliver,etc.Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients With Ulcerative Colitis A Randomized Clinical Trial[J].2019,321(2).
[43]Pleguezuelos-Manzano Cayetano,Puschhof Jens,Rosendahl Huber Axel,etc.Mutational signature in colorectal cancer caused by genotoxic pks+E. coli[J].2020,580(7802).
[44]Erola,Astó,Iago,Méndez,Sergi,Audivert,etc.The Efficacy of Probiotics, Prebiotic Inulin-Type Fructans, and Synbiotics in Human Ulcerative Colitis: A Systematic Review and Meta-Analysis.[J].2019,11(2).
[45]Pozuelo Marta,Panda Suchita,Santiago Alba,etc.Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome[J].2015,5(1).
[46]Kayama, Hisako,Okumura, Ryu,Takeda, Kiyoshi.Interaction Between the Microbiota, Epithelia, and Immune Cells in the Intestine[J].2020,38.
[47]Gibson, Glenn R.,Hutkins, Robert,Sanders, Mary Ellen,etc.The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics[J].2017,14(8).
[48]Galtier, Matthieu,De Sordi, Luisa,Sivignon, Adeline,etc.Bacteriophages Targeting Adherent Invasive Escherichia coli Strains as a Promising New Treatment for Crohn's Disease[J].2017,11(7).
[49]De Vos, D.,Doskar, J.,Rohde, C.,etc.Silk route to the acceptance and re-implementation of bacteriophage therapy[J].2016,11(5).
[50]tana c.,umesaki y.,imaoka a.,etc.Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome[J].2009.
[51]Ford, Alexander C.,Lacy, Brian E.,Talley, Nicholas J..Irritable Bowel Syndrome[J].2017,376(26).